Host immune system receptors

Host immune system receptors are a broad and heterogeneous class of proteins that mediate the body's recognition of and response to pathogens, damaged cells, and foreign substances (Wikipedia, 2024). This category encompasses innate immune sensors, such as pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) and NOD-like receptors (NLRs), as well as adaptive immune receptors, including T-cell receptors (TCRs) and B-cell receptors (BCRs) (NIH, 2023). These receptors are essential for maintaining homeostasis, as they trigger signaling pathways that lead to inflammation, cytokine production, and the activation of specialized immune cells (Creative Diagnostics, 2024). Dysregulation of these receptor systems is central to the pathogenesis of numerous diseases, including autoimmune disorders, chronic inflammatory conditions, and cancer. Consequently, many of these receptors serve as critical therapeutic targets; for instance, monoclonal antibodies may block cytokine receptors to treat arthritis, while checkpoint inhibitors modulate T-cell receptors to enhance anti-tumor activity (PLOS, 2024). Therapeutic intervention must be carefully managed, as over-suppression can lead to opportunistic infections, while over-activation can result in severe systemic inflammation or autoimmunity.

Other names

Immune receptorsImmunologic receptorsPattern recognition receptorsAntigen receptorsCytokine receptorsChemokine receptors

Drugs targeting these receptors function through various mechanisms, including competitive antagonism to block inflammatory signaling, agonism to stimulate immune activity, or checkpoint inhibition to modulate T-cell responses.